| 11/16/2026 12:17 PM | CVI Investments, Inc. (1649553) Filed by Oncobiologics (1649989) Subject | Form SCHEDULE 13G/A | |
| 10/13/2026 11:47 AM | Empery Asset Management, LP (1469336) Filed by Oncobiologics (1649989) Subject | Form SCHEDULE 13G | |
| 09/30/2026 3:30 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/18/2026 3:30 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/02/2026 3:30 PM | Lundquist Kevin Michael (2074701) Reporting Oncobiologics (1649989) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 09/02/2026 3:32 PM | Lundquist Kevin Michael (2074701) Reporting Oncobiologics (1649989) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2026 12:46 PM | CVI Investments, Inc. (1649553) Filed by Oncobiologics (1649989) Subject | Form SCHEDULE 13G | |
| 08/18/2026 4:29 PM | Oncobiologics (1649989) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/17/2026 3:05 PM | Oncobiologics (1649989) Filer | Form NT 10-Q | |
| 08/14/2026 7:57 PM | Jahr Robert Charles (2076177) Reporting Oncobiologics (1649989) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 6:52 PM | GMS Ventures & Investments (1804598) Reporting Oncobiologics (1649989) Issuer Sukhtian Ghiath M. (1717441) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for OTLK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oncobiologics and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/14/2026 6:54 PM | GMS Ventures & Investments (1804598) Filed by Oncobiologics (1649989) Subject | Form SCHEDULE 13D/A | |
| 08/14/2026 6:39 PM | KENYON LAWRENCE A (1230484) Reporting Oncobiologics (1649989) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 7:30 AM | Oncobiologics (1649989) Filer | Form 424B5 | |
| 08/14/2026 7:36 AM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 7:00 AM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2026 3:49 PM | Oncobiologics (1649989) Filer | Form 424B5 | |
| 07/21/2026 11:15 PM | Oncobiologics (1649989) Filer | Form EFFECT | |
| 07/21/2026 3:37 PM | Oncobiologics (1649989) Filer | Form 424B3 | |
| 07/17/2026 3:05 PM | Oncobiologics (1649989) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 07/16/2026 3:05 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/10/2026 5:02 AM | Oncobiologics (1649989) Filer | Form DEFA14A | |
| 06/26/2026 4:30 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2026 7:46 AM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/03/2026 5:03 PM | Haddadin Yezan Munther (1718004) Reporting Oncobiologics (1649989) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 8:30 PM | GMS Ventures & Investments (1804598) Reporting Oncobiologics (1649989) Issuer Sukhtian Ghiath M. (1717441) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 8:31 PM | GMS Ventures & Investments (1804598) Filed by Oncobiologics (1649989) Subject | Form SCHEDULE 13D/A | |
| 06/01/2026 4:00 PM | Oncobiologics (1649989) Filer | Form DEF 14A | |
| 06/01/2026 4:00 PM | Oncobiologics (1649989) Filer | Form DEFA14A | |
| 06/01/2026 8:15 AM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/29/2026 3:30 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/29/2026 7:30 AM | Oncobiologics (1649989) Filer | Form 424B5 | |
| 05/28/2026 4:09 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 2:24 PM | Haddadin Yezan Munther (1718004) Reporting Oncobiologics (1649989) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 2:29 PM | Oncobiologics (1649989) Issuer Sukhtian Faisal Ghiath (1716033) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 2:15 PM | HILZINGER KURT J (1191504) Reporting Oncobiologics (1649989) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 2:20 PM | Oncobiologics (1649989) Issuer THURMAN RANDY H (1204059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 6:15 AM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/22/2026 4:03 PM | Oncobiologics (1649989) Filer | Form PRE 14A | |
| 05/15/2026 3:31 PM | Oncobiologics (1649989) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/13/2026 4:12 PM | Oncobiologics (1649989) Filer | Form 424B5 | |
Get your evenings back (Ad) The Instant Scanner delivers the night's qualifying setups with exact buy prices and defined exits, in minutes. No hours of flipping through charts, no second-guessing patterns.
It's built for traders who want the result without the ritual: a short list and your evening back.
Black Friday price is $7 versus the regular $247. One payment covers a full year, with no re-bills. Get the Instant Scanner for $7 in the Black Friday sale. |
| 05/13/2026 3:36 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/24/2026 4:17 PM | INTRACOASTAL CAPITAL, LLC (1646799) Filed by Oncobiologics (1649989) Subject | Form SCHEDULE 13G | |
| 04/23/2026 3:30 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/23/2026 6:30 AM | Oncobiologics (1649989) Filer | Form 424B5 | |
| 04/21/2026 3:15 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/07/2026 3:15 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/25/2026 4:04 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/23/2026 4:18 PM | Oncobiologics (1649989) Filer | Form 424B5 | |
| 03/16/2026 8:00 AM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/11/2026 4:15 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/10/2026 3:30 PM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 7:30 AM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/05/2026 10:48 AM | Oncobiologics (1649989) Subject SPHERA FUNDS MANAGEMENT LTD. (1496201) Filed by | Form SCHEDULE 13G/A | |
| 01/26/2026 4:01 PM | Oncobiologics (1649989) Filer | Form DEF 14A | |
| 01/26/2026 4:02 PM | Oncobiologics (1649989) Filer | Form DEFA14A | |
| 01/26/2026 4:03 PM | Oncobiologics (1649989) Filer | Form ARS | |
| 01/02/2026 6:30 AM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/19/2025 4:01 PM | Oncobiologics (1649989) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 12/19/2025 7:30 AM | Oncobiologics (1649989) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |